| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/13/2004 | WO2004039401A2 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 05/13/2004 | WO2004039394A1 Novel composition and methods for the treatment of immune related diseases |
| 05/13/2004 | WO2004039334A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 05/13/2004 | WO2004039332A2 Methods for using osteocalcin |
| 05/13/2004 | WO2004039307A2 Methods and compositions for diagnosing and treating companion animal cancer |
| 05/13/2004 | WO2004039244A2 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | WO2004039148A1 Nonbacterial prostatitis model animal |
| 05/13/2004 | WO2004033720A3 Analytical chip for detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon |
| 05/13/2004 | WO2004031762A3 Method and apparatus for determining the sugar content of fruit |
| 05/13/2004 | WO2004029221A3 Microfluidic device for cell separation and uses thereof |
| 05/13/2004 | WO2004029077A3 Method for producing acylated peptides |
| 05/13/2004 | WO2004027418A3 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 05/13/2004 | WO2004027387A3 Automated regression analysis and its applications such as water analysis |
| 05/13/2004 | WO2004027094A3 Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk) |
| 05/13/2004 | WO2004024333A3 Fluidic system |
| 05/13/2004 | WO2004022711A3 Biomap analysis |
| 05/13/2004 | WO2004020978A8 Formation of metal nanowires for use as variable-range hydrogen sensors |
| 05/13/2004 | WO2004019036A3 Method for identifying substances |
| 05/13/2004 | WO2004017063A3 Device and method for detecting a substance with the aid of a high frequency piezo-acoustic thin film resonator |
| 05/13/2004 | WO2004010861A3 Method system and devices for converting venous blood values to arterial blood values |
| 05/13/2004 | WO2004009840A9 Capture and detection of microbes by membrane methods |
| 05/13/2004 | WO2004005469A3 Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003098187A3 Assays and kits for detecting the presence of nitriles and/or cyanide |
| 05/13/2004 | WO2003097835A3 Pharmaceutical compositions for the treatment of cancer |
| 05/13/2004 | WO2003093785A3 Biochips with surfaces coated with polysaccharide based hydrogels |
| 05/13/2004 | WO2003092467A3 Compositions and methods relating to abca1-mediated cholesterol efflux |
| 05/13/2004 | WO2003087838A8 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 05/13/2004 | WO2003072747A3 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS |
| 05/13/2004 | WO2003065002A3 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria |
| 05/13/2004 | WO2003057014A3 Biomarkers for detecting ovarian cancer |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 05/13/2004 | WO2003049762A3 Immunisation against chlamydia trachomatis |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003044221A9 Microfluidic system for proteome analysis |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003033657A3 Antisense antiviral agent and method for treating ssrna viral infection |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003014381A9 System for detecting protease |
| 05/13/2004 | WO2003006951A9 System and method of determining proteomic differences |
| 05/13/2004 | WO2003003014A9 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 05/13/2004 | WO2002089731A9 Agents for treatment of hcv and methods of use |
| 05/13/2004 | WO2002061041A9 Solubility reporter gene constructs |
| 05/13/2004 | WO2002056025A3 Methods for systematic identification of protein - protein interactions |
| 05/13/2004 | WO2002047460A8 Mass spectrometric multivariate analysis of asphalts |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | WO1992004464A3 Monoclonal antibodies against tenascin |
| 05/13/2004 | US20040093631 Methods and means for determining fitness in plants |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040093170 Method for determining pharmaceutically active substances |
| 05/13/2004 | US20040093166 Interactive and automated tissue image analysis with global training database and variable-abstraction processing in cytological specimen classification and laser capture microdissection applications |
| 05/13/2004 | US20040092842 Integrated blood sampling analysis system with multi-use sampling module |
| 05/13/2004 | US20040092841 Method and apparatus for disease management, detect and monitor illness, measure and modify treatment, illustrate prognosis, optimize outcome, assess organ vitality and predict the timing of non-acute death |
| 05/13/2004 | US20040092804 Non-invasive system for the determination of analytes in body fluids |
| 05/13/2004 | US20040092803 Method of in-vivo measurement of fat content of a body and apparatus therefor |
| 05/13/2004 | US20040092738 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence |
| 05/13/2004 | US20040092726 Rare earth metal salt complexed with macropolycyclic compound |
| 05/13/2004 | US20040092719 Using hydrophobic interaction chromatography to separate and isolated heavy chain modified immunoglobulins |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092603 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092475 Detect therapy for leukocyte sensitive inflammation; administering antibody; hypotensive agents, respiratory system disorders |
| 05/13/2004 | US20040092474 Controlling cell proliferation; contacting cell with reporter molecules; measuring, calibrating activation |
| 05/13/2004 | US20040092456 Identifying agents modulating store-operated Ca2+ entry and thereby modulating glucose uptake; drug screening for antidiabetic agents; type 2 diabetes; diagnosis; coadministering with insulin |
| 05/13/2004 | US20040092452 Adding formulation to dissolution medium having osmolarity of 100-550 mOsmol/L and ph of 7-12, maintaining at 0-50 degrees above glass transition temperature of polylactide and determining amount of peptide in the sample |
| 05/13/2004 | US20040092451 Adding a fibrinogen-precipitating agent to platelet rich plasma and centrifuging |
| 05/13/2004 | US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040092036 Device for analysing analyte compounds and use hereof |
| 05/13/2004 | US20040092035 Assay |
| 05/13/2004 | US20040092030 System for providing biological materials |
| 05/13/2004 | US20040092028 Device for enhancing broad band fluorescence with low loss and biological or chemical optic sensor using the same |
| 05/13/2004 | US20040092027 Using fourier transformed infrared spectroscopy to screen biological fluids and diagnosis pathological conditions |
| 05/13/2004 | US20040092006 Applying activating compound to surface of detector |
| 05/13/2004 | US20040092005 Using acid/alkali hydrolysis to recycle matrix comprising oligonucleotides immobilized via acid-amido bonding; reusable solid support for nucleotide sequences analysis |
| 05/13/2004 | US20040091997 Using immobilized chemoselective biopolymers contained in nutrient and osmotic protective medium to analyze surface of an object |
| 05/13/2004 | US20040091993 Comprises peptides associated with rho/rac-interacting citron kinase for identifying modulators for treatment, diagnosis and prevention of cell proliferative disorders |
| 05/13/2004 | US20040091971 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine |
| 05/13/2004 | US20040091964 Modified proteins, isolated novel peptides,and uses thereof |
| 05/13/2004 | US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer |
| 05/13/2004 | US20040091952 Reagent kit for detecting lupus anticoagulant |
| 05/13/2004 | US20040091948 Identifying checkpoint kinase-1 modulators which decrease drug resistance in cancer cells; antitumor agents |
| 05/13/2004 | US20040091947 Screening strategy for anticancer drugs |
| 05/13/2004 | US20040091945 Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease |
| 05/13/2004 | US20040091944 Method for detecting intracellular cholesterol |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091941 Spotting pattern for placement of compounds in an array |
| 05/13/2004 | US20040091940 Latex particles conjugated two distinct monoclonal antibodies for diagnosis of pancreatitis and pancreatic cancer |
| 05/13/2004 | US20040091939 Device and method for detection of multiple analytes |
| 05/13/2004 | US20040091937 Use of fluorine NMR for high throughput screening |
| 05/13/2004 | US20040091935 Comprises nucleotide sequences coding mycoplasmal protein associated with autoimmune and skin disorders for treating and preventing scleroderma |
| 05/13/2004 | US20040091934 Peptides and their use in assays for cardiovascular disease |
| 05/13/2004 | US20040091933 Methods for genetic interpretation and prediction of phenotype |
| 05/13/2004 | US20040091931 Comprises fusion protein for identifying ligands and/or treatment which modulate transmembrane binding; diagnosis and treatment of asthma, chronic obstructive pulmonary disease, cystic fibrosis, sinusitis, and nervous system disorders |
| 05/13/2004 | US20040091928 Comprises nucleotide sequences coding transmembrane receptors for identification of modulator for diagnosis, prevention and treatment of psychological and schizophrenic disorders |
| 05/13/2004 | US20040091925 Nucleic acid archiving |